Guangzhou Wondfo Biotech Co.,Ltd

Shenzhen Stock Exchange 300482.SZ

Guangzhou Wondfo Biotech Co.,Ltd Capital Expenditure for the year ending December 31, 2023: USD -60.95 M

Guangzhou Wondfo Biotech Co.,Ltd Capital Expenditure is USD -60.95 M for the year ending December 31, 2023, a 27.88% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Guangzhou Wondfo Biotech Co.,Ltd Capital Expenditure for the year ending December 31, 2022 was USD -84.51 M, a -17.63% change year over year.
Guangzhou Wondfo Biotech Co.,Ltd Capital Expenditure for the year ending December 31, 2021 was USD -71.84 M, a -11.78% change year over year.
Guangzhou Wondfo Biotech Co.,Ltd Capital Expenditure for the year ending December 31, 2020 was USD -64.27 M, a -149.55% change year over year.
Guangzhou Wondfo Biotech Co.,Ltd Capital Expenditure for the year ending December 31, 2019 was USD -25.75 M, a -35.33% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

Shenzhen Stock Exchange: 300482.SZ

Guangzhou Wondfo Biotech Co.,Ltd

CEO	Mr. Zhongxiong Peng
IPO Date	June 30, 2015
Location	China
Headquarters	No.8 Lizhishan Road
Employees	3,404
Sector	Healthcare
Industries Biotechnology 3D Printing Clinical Trials Medical Instruments Personal Care Pharmaceuticals

Description

Guangzhou Wondfo Biotech Co.,Ltd, a biological company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious, fertility, and sexually transmitted diseases, as well as immunofluorescence devices to detect cardiovascular diseases, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and other diseases. It also provides blood gas, optical coagulation, and dry chemistry analyzers. The company was founded in 1992 and is headquartered in Guangzhou, China.

Key trends

Past 5 years